SpyGlass Pharma is pursuing a $100 million IPO to advance its glaucoma drug delivery platform through Phase 3 trials. Read ...
Current foundation models outperform trainees on text questions but struggle with multimodal ophthalmic imaging ...
In the year after surgery for primary congenital glaucoma, gas-permeable contact lenses led to significantly better visual ...
Chart Industries ( (GTLS)) has shared an announcement. Chart Industries’ board of directors has appointed Chief Human Resources Officer Gerry Vinci as president of the company, effective January 6, ...
Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential ...
Kerala is steadily positioning itself as one of the country’s most industry-friendly and future-ready States, with artificial intelligence and deep-tech innovation at the core of its industrial policy ...
Memory giants Micron, SK Hynix and Samsung have led a rally in semiconductor stocks this year. Memory prices surged in 2025 and are likely to increase further in 2026 as demand for these chips which ...
Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Want to stay informed with market insights and investing ideas from Morningstar? Sign up for my weekly Smart Investor newsletter here. In this week’s newsletter: Weekly Markets Wrap: Stocks Slip as ...
This was destined to be a Christmas-y week on the Billboard Hot 100. It's a week of chart milestones, as holiday songs hold down the top 24 spots on the Billboard Hot 100, Mariah Carey extends ...
This was destined to be a Christmas-y week on the Hot 100: The week's chart reflects seven full days of holiday listening — streaming, airplay, sales — spanning from Dec. 19 through Dec. 25, with no ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results